This section will contain updates from the pain industry.

AAPM 2020 Ultrasound Preconference Course Supporters

On February 27, AAPM will feature the 2020 Advanced Ultrasound-Guided Pain Medicine Interventions preconference course. We would like to thank our Commercial Supporters for their dedication to pain medicine education by ...
Continue reading

More than 70 Industry Partners to Exhibit at AAPM 2020 Next Week

Preview a list of companies that will be exhibiting at the AAPM Annual Meeting February 27-March 1 in National Harbor. Learn about your therapeutic options for the treatment of acute and chronic pain. 

Continue reading
Topics:

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

​ Full story . 

Lilly's REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription

Full story . 
Topics:

Novel Gene Therapies for Precision Pain Management Published by Pharmafile

 Article emphasizes the need of alternative approaches to manage pain and specifically focuses on the genetics of pain and gene therapy solutions. Full story.  
Topics:

Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with a History of Inadequate Response

Axsome Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that AXS-07, Axsome's novel, oral, multi-mech...
Continue reading
Topics:

Los Angeles Startup Uses AI to Reduce Unnecessary Spine Surgeries

A Los Angeles-based startup recently struck a licensing deal with the University of California- Los Angeles to create a tool that can analyze spine images to help decide whether patients should be a candidate for surgery.

Continue reading
Topics:

AAPM 2020 Resource Center Opportunities

Exhibits, scientific posters, attendee receptions, Meet the Faculty events, and much more are planned for the AAPM 2020 Resource Center. Attendees will have opportunities to connect with colleagues and learn about the la...
Continue reading
Topics:

New Novartis Medicine Adakveo® (crizanlizumab) Approved by FDA to Reduce Frequency of Pain Crises in Individuals Living with Sickle Cell Disease

  Read the full story.
Topics:
FDA

BioElectronics Announces Publication of a Study of the ActiPatch® Medical Device as an Effective Long Term Treatment for Chronic Pain

 BioElectronics Corporation, the maker of non-invasive electroceutical devices, is pleased to announce the publication of a study in the journal Pain Research and Management , titled " A Prospective Six-Month S...
Continue reading

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More